United States v. Andrew Dufresne
Opinion
UNITED STATES DISTRICT COURT FOR THE DISTRICT OF NEW HAMPSHIRE
United States Case No. 16-cr-75-1-PB
v. Opinion No. 2020 DNH 169
Andrew Dufresne MEMORANDUM AND ORDER
Defendant Andrew Dufresne moves for compassionate release pursuant to 18 U.S.C. § 3582(c)(1)(A) (“Section 3582(c)(1)(A)”), as amended by Section 603(b)(1) of the First Step Act of 2018 (“First Step Act”), Pub. L. No. 115-391, § 603(b)(1), 132 Stat. 5194, 5239, or, in the alternative, seeks a recommendation from the court that he serve the final twelve months of his sentence in a residential reentry center, pursuant to 18 U.S.C. § 3624. For the following reasons, I grant Dufresne’s motion for compassionate release subject to the conditions specified in this Memorandum and Order (Doc. No. 23).1 I. STANDARD OF REVIEW
Following its amendment by the First Step Act, the compassionate release statute, codified as Section 3582(c)(1)(A), provides that
the court, upon motion of the Director of the Bureau of Prisons [(“BOP”)], or upon motion of the defendant after
1 Because I grant Dufresne’s motion on these grounds, I need not address his argument for alternative relief.
the defendant has fully exhausted all administrative rights to appeal a failure of the [BOP] to bring a motion on the defendant’s behalf or the lapse of [thirty] days from the receipt of such a request by the warden of the defendant’s facility, whichever is earlier, may reduce the term of imprisonment . . . after considering the factors set forth in [S]ection 3553(a) to the extent that they are applicable . . . .
§ 3582(c)(1)(A). The court may reduce a defendant’s prison sentence if it finds that “extraordinary and compelling reasons warrant such a reduction,” id. § 3582(c)(1)(A)(i), and that “such a reduction is consistent with applicable policy statements issued by the Sentencing Commission,” id. § 3582(c)(1)(A).
The Sentencing Commission’s policy statement (“the policy statement”), which was promulgated prior to the passage of the First Step Act, provides as follows:
Upon motion of the Director of the [BOP] under [Section 3582(c)(1)(A)], the court may reduce a term of imprisonment (and may impose a term of supervised release with or without conditions that does not exceed the unserved portion of the original term of imprisonment) if, after considering the factors set forth in [Section 3553(a)], to the extent that they are applicable, the court determines that —
(1) (A) Extraordinary and compelling reasons warrant the reduction; . . .
(2) The defendant is not a danger to the safety of any other person or to the community, as provided in 18 U.S.C. § 3142(g); and
(3) The reduction is consistent with this policy statement.
U.S. Sentencing Guidelines Manual (“USSG”) § 1B1.13 (U.S. Sentencing Comm’n 2018). The commentary to the policy statement further explains what is meant by “extraordinary and compelling reasons.” It states, in relevant part, that “[p]rovided the defendant meets the requirements of subdivision (2), extraordinary and compelling reasons exist,” USSG § 1B1.13 cmt. n.1, when “[t]he defendant is . . . suffering from a serious physical or medical condition,” id. § 1B1.13 cmt. n.1(A)(ii)(I).
District courts are divided on whether the policy statement remains binding following the enactment of the First Step Act. Cf. United States v. Fox, No. 2:14-cr-03-DBH, 2019 WL 3046086, at *2 (D. Me. July 11, 2019) (collecting cases). I am not aware of any court that has chosen to disregard the policy statement entirely. I conclude, instead, that it “provides helpful guidance on the factors that support compassionate release, although it is not ultimately conclusive given the statutory change.” Id. at *3.
II. BACKGROUND
In 2016, Dufresne “waived indictment and pled guilty to an [i]nformation[,]” charging him with “bank robbery in violation of 18 U.S.C. § 2113(a).” Mot. for Compassionate Release or Alternative Relief (“Mot. for Compassionate Release”), Doc. No. 23 at 2; accord Waiver of an Indictment, Doc. No. 8. His “guideline [sentencing] range . . . was [sixty-three] to
[seventy-eight] months[,]” and I sentenced him to a term of imprisonment of sixty-three months, “to be served consecutive to a sentence he was then serving in the Commonwealth of Massachusetts, with three years of supervised release to follow.” Doc. No. 23 at 2; accord J. in a Crim. Case, Doc. No. 19 at 2–3. “He has served approximately [seventeen] months . . . of his statutory sentence and has another approximate [thirty-seven] months . . . left to serve (allowing for good conduct credit),” Doc. No. 23 at 2, and is presently incarcerated at the Metropolitan Detention Center in Brooklyn, New York (“MDC Brooklyn”), after various transfers between BOP facilities in New Hampshire, Massachusetts, and West Virginia, Doc. No. 23 at 2.
Dufresne currently suffers from chronic obstructive pulmonary disease (“COPD”), asthma, and bronchitis. Doc. No. 23 at 1, 4. He has been prescribed at least three different inhalers to manage his asthma and COPD. Doc. No. 23 at 4. Although he has already undergone several hernia surgeries, he needs another that is presently delayed until “his pulmonary condition” improves. Doc. No. 23 at 4. He also “struggles with . . . Attention Deficit Hyperactivity Disorder . . . and anxiety disorder.” Doc. No. 23 at 9.
In light of his medical conditions, Dufresne submitted two requests for compassionate release to the BOP — first, on April
15, 2020, and a second on April 24. Doc. No. 23 at 6. The BOP denied his requests on April 30. Doc. No. 23 at 6; accord Ex. B to Mot. for Compassionate Release, Doc. No. 23-2. Dufresne administratively appealed. Doc. No. 23 at 6. He then filed this motion for compassionate release on July 25, requesting a sentence reduction to time served, among other relief. Doc. No. 23 at 11. I held a hearing on Dufresne’s motion on August 26.
III. DISCUSSION
Because the BOP denied Dufresne’s request for a reduction in sentence, Doc. No. 23-2; accord Doc. No. 23 at 6, and failed to respond to his administrative appeal within thirty days, Doc. No. 23 at 6, Dufresne has exhausted his administrative rights, and so his motion is properly before me under Section 3582(c)(1)(A). At the hearing on this motion, the government agreed that Dufresne’s medical conditions — namely, his COPD — meet the policy statement commentary’s definition of “extraordinary and compelling reasons” in light of the COVID-19 pandemic. See United States’ Opposition to Def.’s Mot. for Release, Doc. No. 28 at 8 (agreeing that the statement’s “threshold requirement” is met). Other federal district courts have found this requirement is met for defendants with similar medical conditions to Dufresne’s, recognizing COPD, for example, as a medical condition that places a defendant “at a heightened risk of severe illness from COVID-19.” E.g., United States v.
Hernandez, No. 10-CR-1288-LTS, 2020 WL 3893513, at *2 (S.D.N.Y. July 10, 2020) (finding “extraordinary and compelling circumstances” during COVID-19 pandemic for a defendant with COPD, among other illnesses); United States v. McCarthy, No. 3:17-CR-0230 (JCH), 2020 WL 1698732, at *5 (D. Conn. Apr. 8, 2020) (same for a defendant with COPD and asthma); accord Doc. No. 23 at 5 (providing cases); cf. United States v. Hernandez, 451 F. Supp. 3d 301, 303 (S.D.N.Y. 2020) (same for a defendant with asthma). Although the generalized risk of contracting COVID-19 at MDC Brooklyn remains low, the risk specific to Dufresne based on his current health conditions is high, and the potential health ramifications should he contract the virus are severe. See, e.g., Hernandez, 2020 WL 3893513, at *2. I concur, therefore, that the “extraordinary and compelling reasons” are met under the policy statement. Accordingly, I must return to the familiar Section 3553(a) factors and also determine whether Dufresne is “a danger to the safety of any other person or to the community” under Section 1B1.13(1)(B) of the USSG.
Free access — add to your briefcase to read the full text and ask questions with AI
2020 DNH 169 (United States v. Andrew Dufresne) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.